CancerDrs

Brain Cancer clinical trials in Montana

4 actively recruiting brain cancer trials at 7 sites across Montana.

Data from ClinicalTrials.gov · last refreshed

Phase 3 Recruiting Network

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

This trial has two cohorts of patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. All patients must be receiving trastuzumab-based treatment. Both cohorts are bei…

Sponsor: SWOG Cancer Research Network
NCT ID: NCT03418961
Sites in Montana:
  • Community Hospital of Anaconda — Anaconda, Montana
  • Billings Clinic Cancer Center — Billings, Montana
  • Bozeman Deaconess Hospital — Bozeman, Montana
  • Benefis Healthcare- Sletten Cancer Institute — Great Falls, Montana
  • Great Falls Clinic — Great Falls, Montana
View on ClinicalTrials.gov →
Phase 3 Recruiting Network

Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases

Stereotactic radiosurgery (SRS) is a commonly used treatment for brain tumors. It is a one-day (or in some cases two day), out-patient procedure during which a high dose of radiation is delivered to small spots in the brain while excluding…

Sponsor: Canadian Cancer Trials Group
NCT ID: NCT03550391
Sites in Montana:
  • Billings Clinic Cancer Center — Billings, Montana
  • Benefis Sletten Cancer Institute — Great Falls, Montana
View on ClinicalTrials.gov →
Phase 3 Recruiting Industry

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

This is a 3-part study. The purpose of Part 1 of the study is to evaluate the efficacy, safety, and pharmacokinetic (PK) characteristics of safusidenib in participants with recurrent/progressive IDH1-mutant World Health Organization (WHO) …

Sponsor: Nuvation Bio Inc.
NCT ID: NCT05303519
Sites in Montana:
  • Billings Clinic — Billings, Montana
View on ClinicalTrials.gov →
Phase 2 Recruiting Network

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

This phase II trial compares the effect of encorafenib, binimetinib, and nivolumab versus ipilimumab and nivolumab in treating patients with BRAF- V600 mutant melanoma that has spread to the brain (brain metastases). Encorafenib and binime…

Sponsor: SWOG Cancer Research Network
NCT ID: NCT04511013
Sites in Montana:
  • Community Hospital of Anaconda — Anaconda, Montana
  • Billings Clinic Cancer Center — Billings, Montana
  • Bozeman Deaconess Hospital — Bozeman, Montana
  • Benefis Healthcare- Sletten Cancer Institute — Great Falls, Montana
  • Great Falls Clinic — Great Falls, Montana
View on ClinicalTrials.gov →

Medical disclaimer: This page aggregates public ClinicalTrials.gov data. It is not medical advice. Always confirm eligibility and enrollment details with the trial site or your oncologist.

Source: ClinicalTrials.gov API v2 · Last checked: 2026-10-01